Magnus Persson - Dec 30, 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Christopher Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 03:13 PM
Previous filing
Oct 3, 2022
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +2.54K $0.00 2.54K Dec 30, 2022 Common Stock 2.54K $5.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the stock option will immediately vest on the date that it is granted.